Details of the Drug Reposition

General Information of This Drug (ID: DMI5678)

Drug Name
Pirbuterol   DMI5678
Synonyms
Maxair; Pirbuterolum; Pyrbuterol; Pirbuterol acetate salt; CP 24315-1; Maxair (TN); Pirbuterol (INN); Pirbuterol [INN:BAN]; Pirbuterolum [INN-Latin]; CP-24315-1; CP-24,314-1; CP-24,314-14; 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-tert-butylamino ethyl)pyridine, dihydrochloride; 2-tert-Butylamino-1-(5-hydroxy-6-hydroxymethyl-2-pyridyl)ethanol; 6-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)-3-pyridinol; 6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
Therapeutic Class
Bronchodilator Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pulmonary disease DIS6060I 1B10-1F85 Approved [1]
Bronchitis DISBM6EQ CA20 Approved [1]
Pulmonary emphysema DIS5M7HZ CA21.Z Approved [1]
Severe asthma DISAVQI3 CA23 Approved [1]
Bronchiectasis DIS5MYEE CA24 Approved [1]
------------------------------------------------------------------------------------

References

1 Pirbuterol FDA Label